biotech firms expanding glp-1 use beyond diabetes and obesity 2025 ADA '26: Lilly's dominance, Pfizer's 'foundational' drug Roche's 'me-too' option GLP-1 Drugs Market Size to

Medicare pricing $245/month (government price) $50/month copay for beneficiaries Eligibility: BMI 27 + metabolic risk factor (prediabetes, HTN, etc.) BMI 30 + CKD, HF, uncontrolled BP BMI 35 regardless of comorbidities Medicaid Will also receive reduced pricing Rollout depends on state decision timelines This expands coverage to millions of Americans

What is the MOQ (minimum order quantity) for wholesale purchases

C- C , , ,

5.2 Unlocking statistical power for IVF outcome assessment with PSM, self-control via skewed analysis Randomized treatment assignment achieved balance in both known and unknown confounding factors between treatment groups